학술논문
AUGMENT: RELAPSED/REFRACTORY INDOLENT NHL PATIENTS WERE MORE SENSITIVE TO NEXT TREATMENT FOLLOWING LENALIDOMIDE/RITUXIMAB (R2 ) THAN RITUXIMAB/PLACEBO.
Document Type
Article
Author
Source
Hematological Oncology; Jun2019 Supplement S2, Vol. 37, p227-229, 3p
Subject
Language
ISSN
02780232